1. Home
  2. APVO vs IPW Comparison

APVO vs IPW Comparison

Compare APVO & IPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • IPW
  • Stock Information
  • Founded
  • APVO 2016
  • IPW 2018
  • Country
  • APVO United States
  • IPW United States
  • Employees
  • APVO N/A
  • IPW N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • IPW Catalog/Specialty Distribution
  • Sector
  • APVO Health Care
  • IPW Consumer Discretionary
  • Exchange
  • APVO Nasdaq
  • IPW Nasdaq
  • Market Cap
  • APVO 21.7M
  • IPW 18.3M
  • IPO Year
  • APVO N/A
  • IPW 2021
  • Fundamental
  • Price
  • APVO $1.46
  • IPW $29.10
  • Analyst Decision
  • APVO
  • IPW
  • Analyst Count
  • APVO 0
  • IPW 0
  • Target Price
  • APVO N/A
  • IPW N/A
  • AVG Volume (30 Days)
  • APVO 4.5M
  • IPW 22.1K
  • Earning Date
  • APVO 11-10-2025
  • IPW 10-09-2025
  • Dividend Yield
  • APVO N/A
  • IPW N/A
  • EPS Growth
  • APVO N/A
  • IPW N/A
  • EPS
  • APVO N/A
  • IPW N/A
  • Revenue
  • APVO N/A
  • IPW $66,142,779.00
  • Revenue This Year
  • APVO N/A
  • IPW $149.67
  • Revenue Next Year
  • APVO N/A
  • IPW $15.04
  • P/E Ratio
  • APVO N/A
  • IPW N/A
  • Revenue Growth
  • APVO N/A
  • IPW N/A
  • 52 Week Low
  • APVO $1.32
  • IPW $12.38
  • 52 Week High
  • APVO $298.00
  • IPW $48.58
  • Technical
  • Relative Strength Index (RSI)
  • APVO 42.13
  • IPW 99.58
  • Support Level
  • APVO $1.48
  • IPW $0.47
  • Resistance Level
  • APVO $1.57
  • IPW $0.71
  • Average True Range (ATR)
  • APVO 0.09
  • IPW 0.86
  • MACD
  • APVO 0.00
  • IPW 2.63
  • Stochastic Oscillator
  • APVO 0.00
  • IPW 100.00

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About IPW iPower Inc.

iPower Inc is a United States-based online retailer and supplier of consumer home, pet, garden, outdoor, and consumer electronics products. It also operates as a provider of value-added ecommerce services for third-party products and brands. The company's capabilities include a spectrum of online channels, fulfillment capacity, a network of warehouses serving the U.S., last-mile delivery partners, and a differentiated business intelligence platform. The company's sales channels currently include Amazon Vendor, Amazon 3P, Walmart.com, TikTok, Temu, and other marketplaces, as well as its own e-commerce websites, such as simpledeluxe.com and more. Additionally, it is developing in-house branded products and through supply chain partners, which include iPower, Simple Deluxe, and other brands.

Share on Social Networks: